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Abstract
Background: Diabetes mellitus is a major global public health threat. In Australia, as elsewhere, it is responsible for
a sizeable portion of the overall burden of disease, and significant costs. The psychological and social impact of
diabetes on individuals with the disease can be severe, and if not adequately addressed, can lead to the
worsening of the overall disease picture. The Living With Diabetes Study aims to contribute to a holistic
understanding of the psychological and social aspects of diabetes mellitus.
Methods/Design: The Living With Diabetes Study is a 5-year prospective cohort study, based in Queensland,
Australia. The first wave of data, which was collected via a mailed self-report survey, was gathered in 2008, with
annual collections thereafter. Measurements include: demographic, lifestyle, health and disease characteristics;
quality of life (EQ-5D, ADDQoL); emotional well-being (CES-D, LOT-R, ESSI); disease self-management (PAM); and
health-care utilisation and patient-assessed quality of care (PACIC). 29% of the 14,439 adults who were invited to
participate in the study agreed to do so, yielding a sample size of 3,951 people.
Discussion: The data collected by the Living With Diabetes Study provides a good representation of Australians
with diabetes to follow over time in order to better understand the natural course of the illness. The study has
potential to further illuminate, and give a comprehensive picture of the psychosocial implications of living with
diabetes. Data collection is ongoing.
Background
Diabetes mellitus currently affects about 285 million
adults worldwide, and this figure is expected to rise to
over 400 million adults by 2030 [1]. Based on self-
reported data, the prevalence of diagnosed diabetes
among Australian adults is 4.4% [2]. It is possible that
t h et r u ep r e v a l e n c ei sa sm u c ha st w i c et h a t ,a n dl i k e l y
to increase further given an aging population, more
sedentary lifestyles, rising rates of obesity, and a reduc-
tion in the rates of diabetes-related mortality [3-5].
The day to day management of diabetes is demanding
and can take a heavy psychological and social toll,
which may in turn result in poor control of blood glu-
cose levels and an increased risk of complications [6,7].
From the patient’s perspective, minimising the burden
imposed by diabetes requires an approach that ensures
services are integrated, accessible and affordable. They
should also be patient-centred, with a strong emphasis
on supporting patients’ confidence and ability to effec-
tively manage their illness [8,9]. To this end, patient
reported outcomes such as quality of life and assess-
ments of quality of care are becoming more widely used
indicators of health care systems, and are now com-
monly considered to be critical to the evaluation of the
responsiveness of health systems in meeting the needs
of their users [10-12].
There is a growing literature on the interaction
between various patient-reported outcomes, demo-
graphic factors, the self-management of patients with
chronic illnesses, and medical outcomes [13,14]. For
instance, diabetes patients with higher levels of active
self-management enjoy better health outcomes [15,16];
more engaged, informed, confident, and skilled patients
a r em o r el i k e l yt op e r f o r ma c t i v i t i e st h a tw i l lp r o m o t e
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health care needs met [17]. Fostering patients to take on
am e a n i n g f u lr o l ei nt h e i ro w nc a r ei st h e r e f o r ec e n t r a l
to improving quality of care and health outcomes.
There is a need to better understand the realities of
living with diabetes in order to tailor adequate and
appropriate medical and psychosocial interventions
[18,19]. Many studies have focused on quality of life
[20,21], patient activation [15,16], resource utilisation
[22,23], or the clinical aspects of diabetes [24,25], but
there has not been a concerted effort to simultaneously
address all of these in order to gain a more holistic
understanding. The Living With Diabetes Study (LWDS)
described here extends the focus of previous research
into diabetes beyond medical endpoints to encapsulate a
broader range of outcomes that contribute to good
health and improved quality of life. In particular the
LWDS considers: how diabetes affects participants’ qual-
ity of life, including their mental health and well-being;
how satisfied people with diabetes are with the range of
health services they use; how people with diabetes man-
age their condition; and the natural progression of dia-
betes over time. The findings from the LWDS will
provide a more comprehensive picture of the everyday
experiences of people living with diabetes and inform
health policy planning and service delivery.
Methods/Design
Study design and sampling scheme
The LWDS is a 5-year, prospective cohort study being
conducted in the state of Queensland, Australia. Data
are collected via a mailed self-report questionnaire.
Baseline data were collected in 2008 and follow-up mea-
surement waves occur annually.
Participants were recruited from the National Diabetes
Services Scheme (NDSS), a government initiative admi-
nistered by Diabetes Australia that delivers diabetes-
related products at subsidised prices to registrants. In
order to register with the NDSS, an individual must
receive certification of a diagnosis of diabetes from a
doctor or diabetes educator. The NDSS is estimated to
cover 80%-90% of the Australian population diagnosed
with diabetes [26].
People were eligible to participate in the LWDS if
they: were aged 18 years or older; had been diagnosed
with type 1 or type 2 diabetes (gestational diabetes was
excluded); had a valid Queensland postal address
recorded with the NDSS; and indicated on their NDSS
registration that they were interested in receiving infor-
mation about opportunities to participate in research.
The final criterion reduced the population available for
sampling from 133,851 to 58,504.
The LWDS sampling scheme oversampled in three
areas of policy interest in Queensland: an outer
metropolitan area, a new suburban development and a
coastal agricultural community. These areas of policy
interest contain approximately 7% of potential partici-
pants. While the focus of the LWDS is on documenting
the lived experience of diabetes for the entire cohort,
differences between these three geographically distinct
areas of interest will be provided to the local state health
authority for policy and planning purposes. Where
appropriate findings from the cohort are weighted to
adjust for the oversampling.
The sample size was calculated based on detecting an
absolute change in the percentage of participants with
poor health-related quality of life of at least 2.5%
between the start and the end of the study. The preva-
lence of poor health-related quality of life among
Queenslanders with diabetes at study initiation was esti-
mated at 30% [27]. To detect an absolute change of
2.5% or greater with 90% power and alpha = 0.05 we
calculated we required 3,457 participants to remain in
the study at completion. To achieve this, and assuming
2% of addresses on the database would be invalid, 40%
of individuals invited to enter the study at baseline
would participate, and that each year 10% of participants
would leave the study, we were required to invite 14,350
eligible individuals to participate in the LWDS. All eligi-
ble individuals from the three areas of policy interest
were invited to participate (45% of all invitees), the
remainder of invitees were from the rest of Queensland.
Follow-up, retention and participant tracking
In order to encourage people with diabetes to partici-
pate in the study at baseline, a multi-stage follow-up
procedure was used following the initial survey package
mail-out. Approximately 3 weeks after the initial mail-
out, all potential participants were sent a letter designed
to thank those people who had returned the survey and
prompt those who had not yet returned the question-
naire. Six weeks after the initial mail-out, potential parti-
cipants who had still not returned a survey were sent a
replacement survey package. No further follow-up at
baseline was permitted by the NDSS.
In order to minimise non-response for subsequent
annual data collection waves, in addition to the thank
you/reminder letter and targeted replacement survey
mail-outs, targeted reminder letters are sent to those
participants who have still not returned a survey 3
weeks after the replacement survey mail-out (i.e. 9
weeks after the initial mail-out). In 2010, due to con-
cerns about the retention rate, targeted reminder tele-
phone calls were also made to those participants who
had still not returned a survey after the replacement
surveys were sent out.
In order to further maximise retention of cohort parti-
cipants following recruitment, a range of additional
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follow-up data collections, all participants are sent a
small incentive with the questionnaire (e.g. $1 ‘scratch-
it’ ticket in 2009 and a pen in 2010), and those who
return the questionnaire go into a draw to win one of
five $1,000 cash prizes. Other strategies include record-
ing the contact details of two alternative contacts for
each participant at baseline to assist with tracking; a
study website and freecall 1800 number which allows
people to update their contact details; biannual study
newsletters for participants providing study findings as
well as a reminder to update contact details; the inclu-
sion of study synopses in relevant consumer-based orga-
nisations’ newsletters; and a reminder package, which
includes a postage-paid change of address card, sent 4
weeks before the annual survey mail-out.
A participant tracking system involves contacting
alternative contacts for participants whose survey
packages are ‘returned to sender’ (RTS) or who are
unable to be contacted by telephone during follow-up. If
no alternative contacts have been provided an online
electronic phonebook is used in an attempt to track the
participants. Data linkage to Australia’s National Death
Index (NDI) occurs annually prior to each data collec-
tion to identify deceased LWDS participants.
Response rates
The participation rate at baseline was 29% after notified
deaths and RTS were omitted (5.6%; n = 813). A study
flow chart is presented in Figure 1. The retention rate in
2009 was 88% after notified deaths and RTS were
omitted from calculations. This figure was 86% for the
2010 data collection.
Participants versus non-participants
A previous analysis, using aggregated data provided by
NDSS, compared the study’s participants with non-parti-
cipants, as well as the study’s participants with all other
NDSS registrants in Queensland including those who on
their NDSS registration form did not consent to
research participation [28]. The findings showed that
participants were more likely than non-participants to
be aged 50 to 69 years and to be non-indigenous Aus-
tralians (see Table 1). The analyses comparing study
participants with the broader population of NDSS regis-
trants showed that the study’s participants were more
a =actively indicated on their NDSS registration that they were willing to be informed about opportunities to participate in research 
Total 2008 responders 
available for analysis 
N = 3951 
Baseline participation=29% 
(less deceased and RTS) 
Deceased N = 103 
Incorrect address in NDSS register 
(RTS) N = 710 
2008 cohort 
No signed consent form 
with data 
N=7 1
Deceased N = 41 
Lost N = 11 
2008 cohort 
Signed consent form and 
data 
N = 3880
Total 2009 responders 
available for analysis 
N = 3360 
Response rate=88%  
(less deceased and lost) 
Eligible NDSS Registrants 
Queenslanders’ aged 18 years and older with either type 1 or type 2 
diabetes who were willing research participants
a 
N=58,504 
Invited eligible study participants 
(based on power calculations) 
N=14,439 
Active 2009 cohort  
N = 3887 
Deceased N = 40 
Lost N = 22 
Active 2010 cohort 
N = 3772 
Total 2010 responders 
available for analysis 
N = 3182 
Response rate=86% 
(less deceased and lost) 
2008 cohort 
Signed consent form no 
data 
N=7
Withdraw N = 63 
Figure 1 Flow chart of study design and response rates.
Table 1 Comparison between LWDS participants and
non-participants (adapted from David, Ware, Donald et
al., 2011)
Participants Non-
participants
OR (95% CI)
N = 3,951 N = 10,488
Sex
Male 2,176
(55.1%)
5,885 (56.1%) 1
Female 1,775
(44.9%)
4,603 (43.9%) 1.01 (0.93-
1.10)
Age
18-49 618 (15.6%) 2,246 (21.4%) 0.67 (0.60-
0.75)
50-69 2,375
(60.1%)
5,649 (53.9%) 1
70+ 958 (24.3%) 2,593 (24.7%) 0.88 (0.80-
0.97)
Diabetes Status
Type 2 No Insulin 3,023
(76.5%)
8,024 (76.5%) 1
Type 2 Insulin 738 (18.7%) 1,986 (18.9%) 0.97 (0.87-
1.08)
Type 1 Insulin 190 (4.8%) 478 (4.6%) 1.11 (0.91-
1.34)
Registration Year
2001-2003 1,303
(38.0%)
3,422 (37.0%) 1
2004-2005 805 (23.4%) 2,239 (24.2%) 0.96 (0.85-
1.07)
2006-2008 1,325
(38.6%)
3,580 (38.8%) 1.01 (0.92-
1.12)
Socioeconomic
status
Low 830 (21.0%) 2,491 (23.8%) 1
Middle 1,543
(39.1%)
3,883 (37.1%) 1.13 (1.01-
1.27)
High 1,572
(39.9%)
4,100 (39.1%) 1.11 (0.99-
1.24)
Indigenous
No 3,838
(97.2%)
9,969 (95.1%) 1
Yes 113 (2.8%) 519 (4.9%) 0.57 (0.45-
0.71)
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years, be recently registered with the NDSS scheme and
be non-indigenous Australians. In addition, there was an
underrepresentation of patients with type 1 diabetes
among study participants (4.8%) compared to NDSS
registrants (14.5%).
Measures and instruments
The study collects information on a range of issues,
including the primary outcomes of interest–quality of
life and quality of care. Clinical outcomes such as the
onset of diabetes complications and HbA1c are also
measured. An overview of the components of the survey
is provided in Table 2. Information relating to 347 pri-
mary variables was collected in the 2008 LWDS ques-
tionnaire. A copy of the questionnaire is available from
the authors on request or can be downloaded from the
study’s website at http://www.lwds.org.au.
The NDI will be used to identify premature deaths,
and cause of death data will be accessed at the comple-
tion of the study. In addition, a proposed data linkage to
Australia’s Medical Benefits Scheme (MBS) and Pharma-
ceutical Benefits Scheme (PBS) has also gained ethics
approval and will provide information about individual
participant’s use of government subsidised health ser-
vices and medications. Access to these administrative
data will not only provide information to verify self-
report health care utilisation data, but will also allow for
more detailed examination of the timing of services and
health outcomes.
Main outcomes of interest
Health-related quality of life
The EQ-5D, developed by the EuroQoL Group, is widely
used in clinical trials, observational studies and health
surveys, and has been translated into most major lan-
guages [35,48]. The measure includes a descriptive sys-
tem comprising five dimensions and a visual analogue
scale. The dimensions measured are: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression.
To complete the visual analogue scale respondents are
asked to rate their current health status on a scale from
0t o1 0 0 ,w h e r e0i st h ew o r s ti m a g i n a b l eh e a l t ha n d
100 is the best imaginable health. The EQ-5D also pro-
vides a preference-based utility index where responses
a r ec o n v e r t e dt oas i n g l ew e i g h t e ds c o r e .T h i sg i v e sa
Table 2 Summary of main variables collected
Section Examples of Variables Measures and Standardised Scales
A: Disease-
related factors
Type of diabetes and Disease duration
Glycaemic control, Treatment type, Diabetes Complications &
Co-morbidity
Diabetes type verified using NDSS data
B: Health and
Lifestyle
Nutrition
Smoking status
Alcohol consumption
Physical activity
Height, Weight,
Sleep patterns (2010 only)
Dietary Guidelines for Australian Adults [29]
National Drug Strategy Household Survey [30]
Frequency-quantity measure
# & National Health and Medical
Research Council Guidelines [31].
Active Australia Survey [32] & National Physical Activity
Guidelines for Australians [33]
Body Mass Index adapted from WHO [34]
C: Quality of Life Health related quality of life
Diabetes-specific quality of life
Euroqol EQ-5D [35]
Audit of Diabetes Dependant Quality of Life (ADDQoL) [36,37]
D: Disease
management
Self-management
Compliance with providers recommendations
Disease management resources (2010 only)
Patient Activation Measure (PAM) [38]
Summary of Diabetes Self-Care Activities (Modified) [39]
Chronic Illness Resources Survey (CIRS) [40]
E: Health care
utilisation
Primary care visits
Allied health visits
Emergency department visits
Hospitalisations and reasons
F: Quality of care Patient-assessed quality of care
Satisfaction with care (access, coordination)
Practitioner compliance with guidelines
Patient Assessment of Chronic Illness Care (PACIC) [41]
Australian Diabetes Management in General Practice
guidelines [42]
G: Emotional
well-being
Depressive symptomatology
Stressful life events
Optimism (2009, 2010)
Social Support (2009, 2010)
Centre for Epidemiological Studies: Depression Scale (CES-D)
[43]
Life Orientation Test - Revised (LOT-R) [44]
ENRICHED Social Support Inventory (ESSI) [45]
H: Socio-
demographics
Age, Sex, Marital status, Ethnicity, Employment status,
Educational status & Household income
Private health insurance; Health concession cards, Out of pocket
health costs
Derived from Australia’s National Health Survey questions [46]
# The frequency-quantity method used to measure alcohol consumption in the LWDS is a relatively conservative estimate of high risk alcohol consumption [47]
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dead are included. An EQ-5D score of 1 corresponds to
perfect health; 0 to indifference between death and liv-
ing; and, any numbers less than 0 to a state where death
is preferred.
Diabetes-specific quality of life
The ADDQoL consists of two overview items; one mea-
sures generic overall quality of life and the second mea-
sures the specific impact of diabetes on quality of life. A
further 19 domains concerned with the impact of dia-
betes on specific aspects of life are also measured. Parti-
cipants are asked to rate the impact of diabetes on each
domain and the importance of the domain for their
quality of life. These two scores are then multiplied to
yield a weighted impact score for each domain (range -9
to +3). Finally, an average weighted impact score is then
calculated for the entire scale.
Quality of care
Respondents completed the Patient Assessment of
Chronic Illness Care (PACIC), which measures the
extent to which patients report receiving care that is
consistent with the dimensions of the Chronic Care
Model (CCM) [49]. The PACIC consists of 20 items
with each item scored using a five point scale, ranging
from 1 being none of the time to 5 being always. The
items aggregate into five sub-scales that align with the
dimensions of the CCM: patient activation, delivery
system design/decision support, goal setting/tailoring,
problem solving/contextual, and follow-up/coordina-
tion. Patient activation assesses the extent to which the
patient was motivated and supported by the physician
to initiate changes. Delivery system design/decision
support assesses the degree to which the patient was
supported (e.g. by information sheets), and how satis-
fied the patient was with the organisation of that care.
Goal setting/tailoring assesses to what extent general
instructions and suggestions were adapted to the
patient’s personal situation. Problem solving/contextual
addresses how the physician dealt with problems
which interfered with achieving predefined goals.
Finally, follow-up/coordination addresses how fre-
quently and consistently the care process was fol-
lowed-up. Each sub-scale is scored by averaging across
the items within that sub-scale, with an overall PACIC
score obtained by averaging across all 20 items. Higher
scores indicate higher quality care.
To provide another measure of quality of care, partici-
pants completed a series of purpose-designed quality
indicators based on specific aspects of care recom-
mended in the Australian Diabetes Management in
General Practice guidelines [42], by indicating whether a
member of their medical team had undertaken the care
activity in the preceding 12 months.
Ethics
Ethics approval for the study was granted by the Univer-
sity of Queensland’s Behavioural and Social Sciences
Ethical Review Committee. Written informed consent
was obtained from all individuals followed over time.
Consent forms are removed from returned surveys and
stored in a locked filing cabinet.
Data management and statistical analyses
After entry, data is both manually and statistically
checked during the data-cleaning process. Data are veri-
fied against the returned surveys when necessary. Elec-
tronic scanned copies of all original surveys are kept on
file in a password-protected data file while hard copies
are destroyed.
Initially, descriptive statistics are calculated for all vari-
ables. Where appropriate proportions are weighted to
adjust for the oversampling, and unweighted sample
sizes and weighted percentages are reported. Change
over the follow-up period will be assessed using general-
ised estimating equations (GEE), which will allow for
the best use of all data collected as GEEs do not require
balanced data sets. Using GEEs will allow the data of all
individual participants to be included in analyses, irre-
spective of the level of questionnaire completion.
The exact final method of analysis will be outcome-
dependent. However, as a rule all associations will be
assessed in the following stepwise manner: (a) univariate
analysis: only adding the specific independent variable to
the model; (b) a multivariate model to establish the sig-
nificant associations; (c) adjusting for age, gender and
socio-economic indicators to explore potential con-
founding factors; and (d) the addition of potential effect-
modifiers by using interaction terms wherever necessary.
Baseline characteristics of the sample
Baseline socio-demographic characteristics of the sample
are presented in Table 3 for the purpose of assessing the
potential generalisability of the findings to Australians
with diabetes. Fifty-five percent of the research partici-
pants were male. Participants’ age ranged from 18 to 94
years. The overall mean age was 61.4 years (SD = 12.1).
Educational status varied; 13.4% of participants had com-
pleted university study, while almost half (46.5%)
reported education to grade 10 (i.e. junior certificate) or
lower. A large proportion of the sample (44.5%) was
retired. Only 1.8% of the study population reported being
of Indigenous origin. Almost two thirds of participants
live in households earning less than $60,000 (AUD) per
annum, while 30.6% of LWDS households earned less
than $20,000 (AUD) per annum. 62.0% of LWDS partici-
p a n t sr e p o r t e dt h a tt h e yh o l dah e a l t hc a r ec a r dw h i c h
provides access to subsidised health care.
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LWDS sample are summarised in Table 4. The median
duration of time since receiving a diagnosis of diabetes
was 5 years and the mean was 6 years (range: less than
1 year to 50 years). Overall, 83% of participants reported
being diagnosed within the past 8 years, with more than
half (69.7%) managing their diabetes with oral hypogly-
caemic drugs. Approximately one out of five participants
was insulin requiring. Erectile dysfunction was the most
commonly reported diabetes complication among men
(41.4%), followed by diabetes related eye disease (e.g.
retinopathy, cataracts, glaucoma), which was the highest
among women. Overall, one in ten LWDS participants
smoked daily. More than four out of five participants
were overweight, with half being obese or morbidly
obese.
Given established differences between males and
females on several factors with likely implications for
intervention, Table 4 also presents medical and lifestyle
characteristics stratified by gender. Sub-group analysis
by gender showed no significant differences for the dia-
betes-specific characteristics such as type of diabetes,
length of diagnosis or HbA1c levels. However, gender
specific differences were observed for several diabetes
complications: including foot ulcers, cardiovascular
disease and stroke. In addition, females were more likely
than males to report co-morbid depressive symptoma-
tology. With the exception of current smokers, statisti-
cally significant gender differences were observed for
Table 3 Baseline socio-demographic characteristics
Socio-demographic characteristic All Persons
n = 3951
%
Gender
Male 2175 55.1%
Female 1776 44.9%
Age
18-44 year 343 8.7%
45-59 year 1204 30.5%
60-74 year 1921 48.6%
75 + year 483 12.2%
Education Level
University degree 516 13.4%
Certificate/diploma/trade 1044 27.2%
Senior high school 495 12.9%
Year 10 and below 1789 46.5%
Employment Status
Full time/part time/self-employed 1521 39.1%
Home duties/carer/volunteer 241 6.2%
Unemployed (but able to work) 94 2.4%
Retired 1729 44.5%
Unable to work 301 7.8%
Married or living as married 2766 70.8%
English speaking background 3750 98.2%
Indigenous Australian 70 1.8%
Household annual income < $60,000(AUD) 2540 73.7%
Health concession cards (yes) 2394 62.0%
Table 4 Baseline medical and lifestyle factors
Medical or lifestyle factor All
Persons
Males Females p-
value
Medical
Type of diabetes
Type 1 4.8% 4.5% 5.2% 0.256
Type 2 95.2% 95.5% 94.8%
Length of diagnosis
2 years or less 25.5% 25.4% 25.6% 0.298
3 to 8 years ago 57.5% 56.7% 58.3%
More than 8 years ago 17.0% 17.8% 16.1%
Diet only treated diabetes 4.1% 3.8%
%
4.4% 0.372
Current oral hypoglycaemic
agents
69.7% 71.8% 67.7% 0.005
Insulin requiring 21.6% 22.7% 20.2% 0.055
HbA1c Levels
7.0% or lower 48.7% 48.2% 49.2%
7.1%-8.0% 21.7% 22.4% 20.8% 0.070
Over 8.0% 14.3% 15.1% 13.3%
Don’t know 15.4% 14.3% 16.7%
Lipid-lowering agents 52.1% 52.8% 51.0% 0.224
Antihypertensive therapy 57.3% 57.9% 56.6% 0.412
Current depression 38.5% 35.7% 41.8% < 0.001
Diabetes Complications
Eye disease 23.3% 23.7% 22.8% 0.500
Kidney disease 6.2% 6.8% 5.5% 0.090
Neuropathy 8.8% 9.4% 8.2% 0.192
Erectile dysfunction - 41.4% - -
Foot ulcers 2.1% 2.6% 1.5% 0.017
Heart disease
a 15.4% 19.4% 10.6% < 0.001
Stroke or transient ischaemic
attack
5.1% 6.0% 3.9% 0.003
Behavioural lifestyle
Inadequate fruit consumption 39.5% 43.4% 34.8% < 0.001
Inadequate vegetable
consumption
87.2% 90.1% 83.6% < 0.001
Insufficient physical activity
b 50.7% 45.2% 57.3% < 0.001
Current smokers 10.5% 10.7% 10.2% 0.619
Risky alcohol consumers 6.6% 8.5% 4.6% < 0.001
BMI (mean = 31.1 ± 6.9 kg/m
2)
Underweight 0.5% 0.2% 0.9% < 0.001
Normal 16.4% 15.7% 17.3%
Overweight 33.3% 39.2% 25.9%
Obese or morbidly obese 49.7% 44.9% 55.8%
a includes heart disease, angina, heart attack, irregular heart rhythm, missed
heart beats or blocked artery in the heart
b insufficient for health benefit is defined as less than 150 min of at least
moderate-intensity physical activity over at least five sessions in the previous
week (18-75 years only)
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index (BMI).
Discussion
This paper describes the study rationale and procedures
for the LWDS and reports the baseline characteristics of
a cohort of 3951 people with diabetes. The approach of
the LWDS differs from other national and international
studies of diabetes in its focus on examining the natural
trajectory of diabetes and its treatment from a psychoso-
cial perspective. It is hoped that this will lead to a
greater understanding of how to improve the life and
quality of care of people with diabetes. The large cohort
will allow for the undertaking of multivariate statistical
analyses, and the longitudinal nature of the data enables
the investigation of temporal effects.
Wherever possible standardised scales and questions
were used in the LWDS questionnaire to measure the
domains of interest. We relied on previous health ser-
vices research and psychosocial research to select mea-
sures sensitive to change and with adequate face,
content and construct validity. The importance of dis-
tinguishing between health-related quality of life and
disease-specific quality of life has been highlighted by
previous researchers [11,50]. On this basis, both are
measured in the LWDS. Health-related quality of life
measures a patient’s symptoms and functioning. The
EQ-5D is one of the most widely used preference-based
measures of health-related quality of life [51]. Disease-
specific quality of life, which captures the broader multi-
dimensional, subjective and dynamic features of quality
of life, relates more specifically to a person’s perception
of how a specific disease has impacted on their life [52].
Disease-specific measurement instruments include those
aspects of life considered to be the most important by
patients and clinicians resulting in a more detailed
assessment of the issues and concerns relevant to the
specific disease, its treatments and complications
[13,37,53]. Several recent reviews of diabetes-specific
quality of life instruments conclude that there is good
evidence that the ADDQoL, used in the LWDS, is a reli-
able measure of disease-specific quality of life with good
face and content validity [52-55]. A recent assessment of
37 measures of patient-assessed quality of care designed
for use with people with chronic illness found the
PACIC, used in the LWDS, to be the most appropriate
as determined by its psychometric properties and per-
ceived applicability and relevance [41]. The inclusion of
these self-reported patient assessments of quality of life
and quality of care will allow for the reliable assessment
of the impact that the progression of diabetes has on
these important health and well-being outcomes.
The LWDS study has the inherent limitations of self-
report surveys. The reliability and validity of self-report
health measures varies across behaviours and outcomes.
Self-reported health service utilisation data is subject to
recall bias and underreporting, especially for older adults
and frequent users of primary care [56,57]. Cross-refer-
encing the self-report service utilisation data with MBS
data will improve the reliability and validity of this infor-
mation. Self-report data on health information, such as
co-morbidities, has been found to be of variable quality,
but is generally satisfactory for well-known conditions
[58,59]. Previous research has found a positive, albeit
weak, correlation between self-reported HbA1c values
and medical record data [60]. Self-report of treatment
types including oral agents and insulin use are generally
valid [61].
While recruitment at baseline was slightly lower than
anticipated, it is similar to that of other studies of this
nature [62] and is consistent with research showing that
participation rates in large cohort studies appear to be
decreasing. It is estimated that rates have declined from
about 80% to 30% or 40% over the past several decades
[63]. Effective participant retention is vital to the success
of the LWDS and we have instituted an anti-attrition
strategy to ensure as many cohort members as possible
remain in the study. Past research suggests that the
attrition in follow-up for postal surveys can be decreased
by the provision of a monetary incentive such as a lot-
tery ticket or a prize [64], with the magnitude less
important than an incentive per se [65]. Although losses
to follow-up are inevitable, the study’sc o m p r e h e n s i v e
retention strategy to date has been successful in limiting
participant drop-out. However, it is possible that those
individuals whose health deteriorates more markedly
over time will discontinue study participation, biasing
findings towards healthier participants.
Use of a national disease register with high coverage
of the target population in the recruitment process has
been effective for enrolling a large representative sample
of people with diabetes, covering a broad range of
socio-demographic and clinical characteristics. Specifi-
cally, the proportion of males was consistent with esti-
mates provided by Australia’s National Health Survey
that 56% of Australians with diabetes are male [2]. The
large proportion of LWDS participants with low levels
of educational attainment is not unexpected given the
older age distribution of the sample. Similarly, it is
unsurprising that a large proportion of the sample
(44.3%) was retired and one in 15 reported being unable
to work.
In 2005-06 the average gross annual household
income in Australia was around $68,000 (AUD) [66].
While it is difficult to make direct comparisons based
on the income brackets used in the LWDS, the finding
that 73.7% of participants live in households earning less
than $60,000 (AUD) per annum indicates that overall
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the general population of Australians. This differential is
consistent with what would be expected given the pre-
viously reported relationship between low socio-eco-
nomic status and prevalence of diabetes [67,68] as well
as the high levels of retirement among the LWDS
participants.
A similar pattern holds for health concession cards. In
Australia low income is one of the criteria for eligibility
for a government health concession card. Possession of
the card can significantly reduce the out-of-pocket
expenses for consumers through subsidised medical
care, hospital treatment and some medications. Austra-
lia’s 2004-05 National Health Survey reported 35% of
persons 15 years and over were covered by a govern-
ment health card, a figure considerably lower than the
62.0% of LWDS participants reporting that they hold a
health care card. The higher LWDS proportion will
most likely be accounted for by the older age and
poorer health status of people with diabetes.
Another area in which the study is not representative
of the general population relates to the proportion of
Indigenous Australians. Research shows that diabetes is
more common among Indigenous Australians [69] than
among their non-Indigenous counterparts. However,
with census data showing that 2.5% of the Australian
population report an Indigenous background [70] and
only 1.8% of the study population reporting that they
are of Indigenous origin the LWDS cannot be general-
ised to this population.
Less than one in 20 LWDS participants relied on diet
alone as the treatment pathway for their diabetes. Pre-
vious researchers have suggested that people managing
their diabetes through diet and exercise alone may not
have a high level of need for the NDSS’ss e r v i c e sa n d
would therefore be less likely to register with the
scheme [26]. Our findings support this assumption. Less
than 5% of the LWDS sample reported having a diagno-
sis of type 1 diabetes. The true prevalence of type 1 dia-
betes in Australia is estimated to be approximately 10%
[2]. The underrepresentation of patients with type 1 dia-
betes is attributed to the lower likelihood of NDSS
registrants with type 1 diabetes consenting to participate
in research as there is not systematic updating of
research consent status at the age of 18 among those
registered as a child [28]. We acknowledge this as a
weakness of the LWDS with implications for the gener-
alisability of the study to people with type 1 diabetes.
Future analyses of the data will stratify by diabetes type.
On the other hand, the diabetes complications
reported by the LWDS participants at baseline were
very much in keeping with the available Australian sta-
tistics for the Australian diabetic population as a whole
[71]. For example, 2.1% of respondents reported having
foot ulcers, with the available comparable figure for the
entire Australian diabetic population also 2.1%. Addi-
tionally, 6.2% of the sample, compared to 6.3% of the
Australian diabetic population, reported kidney disease;
5.1% of the sample compared to 5.0% of the Australian
diabetic population reported having had a stroke; 8.8%
o ft h es a m p l ev e r s u s8 . 6 %o ft h eA u s t r a l i a nd i a b e t i c
population reported neuropathy; and 41.4% of men on
the study reported erectile dysfunction as a complica-
tion, while 30.2% of the general male diabetic population
had the same complaint. The discrepancy for erectile
dysfunction may stem from the differing data collection
methods used to obtain the estimates.
Lifestyle changes constitute an important aspect of
the management of diabetes, in particular type 2 dia-
betes. For example, obesity in those with type 2 dia-
betes complicates management of the disease by
increasing insulin resistance and with that, blood glu-
cose concentrations. This however, is reversible, such
that weight loss of just 5% of body weight may
improve insulin sensitivity and glycaemic control
[72,73]. Research undertaken with US adults found
t h a tt h o s ew i t hd i a b e t e sw e r em o r el i k e l yt ob ep h y s i -
cally inactive (61%) than those without diabetes (42%)
[74]. Recent comparable physical activity rates for the
Australian general population are not available. We
can however compare the LWDS with the Australian
Diabetes, Obesity and Lifestyle Study (AusDiab) con-
ducted in1999 -2000 which found that 59.3% of Aus-
tralians with diabetes were insufficiently active [75],
which is higher than the 50.7% found for the LWDS
sample. Recent suggestions of a trend towards
increased levels of physical activity among Australians
may explain the difference [76]. It is well established
that on average people with diabetes are more likely to
be overweight than people without diabetes. Both the
LWDS and the AusDiab study [71] found that approxi-
mately four out of five diabetic patients are overweight
or obese. The baseline estimates for health risk beha-
viours for participants of the LWDS suggest that there
is considerable scope for behavioural lifestyle modifica-
tion among Australians with diabetes.
The wide range of information collected from the
LWDS participants allows for an in-depth exploration of
the multidimensional nature of diabetes. The availability
of longitudinal data allows the LWDS to contribute
towards a deeper understanding of the dynamics of liv-
ing with diabetes; and to build complex psychosocial
models of the determinants of disease progression, qual-
ity of life and models of patients’ assessments of the
quality of their care. This will allow for the identification
of key targets for intervention strategies, and will contri-
bute to public health policy, especially as it relates to
resource allocation and planning.
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